Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Small cell lung cancer cells (SCLC) are differentially sensitive to inhibitors of the BCL-2 family. Here the authors analyse the response to BH3 mimetics in SCLC, delineate patterns of expression of apoptotic proteins correlated with differential sensitivities and demonstrate a synergistic anti-tumo...
Main Authors: | Akane Inoue-Yamauchi, Paul S. Jeng, Kwanghee Kim, Hui-Chen Chen, Song Han, Yogesh Tengarai Ganesan, Kota Ishizawa, Sylvia Jebiwott, Yiyu Dong, Maria C. Pietanza, Matthew D. Hellmann, Mark G. Kris, James J. Hsieh, Emily H. Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms16078 |
Similar Items
-
ΔNp63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival
by: Gary X. Wang, et al.
Published: (2017-12-01) -
Structural insights into apoptotic regulation by BCL-2 family
by: Liu, Qian
Published: (2010) -
Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins
by: Foight, Glenna W., et al.
Published: (2017) -
Two independent positive feedbacks and bistability in the Bcl-2 apoptotic switch.
by: Jun Cui, et al.
Published: (2008-01-01) -
Bcl-xL promotes metastasis independent of its anti-apoptotic activity
by: Soyoung Choi, et al.
Published: (2016-01-01)